THE ROLE OF POSITRON EMISSION TOMOGRAPHY IN ONCOLOGY AND OTHER WHOLE-BODY APPLICATIONS

被引:74
作者
HAWKINS, RA
HOH, C
GLASPY, J
CHOI, Y
DAHLBOM, M
REGE, S
MESSA, C
NIETSZCHE, E
HOFFMAN, E
SEEGER, L
MADDAHI, J
PHELPS, ME
机构
[1] UNIV CALIF LOS ANGELES,SCH MED,US DOE,NUCL MED LAB,LOS ANGELES,CA 90024
[2] UNIV CALIF LOS ANGELES,SCH MED,BIOMED & ENVIRONM SCI LAB,LOS ANGELES,CA 90024
[3] UNIV CALIF LOS ANGELES,SCH MED,CRUMP INST BIOL IMAGING,LOS ANGELES,CA 90024
[4] UNIV CALIF LOS ANGELES,SCH MED,DIV HEMATOL & ONCOL,LOS ANGELES,CA 90024
关键词
D O I
10.1016/S0001-2998(05)80121-7
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Imaging and quantifying biochemical and physiological processes with PET clearly has major potential significance for all organ systems and many disease states. Although the full utility and potential of emerging new applications of PET in organs other than the heart and brain must be demonstrated in basic and clinical research studies, the rapidly accumulating aggregate experience in oncology in particular, and in other organ systems and disease states as well, indicates that PET is now truly becoming a modality of both clinical and investigative use for the body as a whole as well as for specific organ systems. Wholebody PET FDG imaging (Fig 9) illustrates the potential of biochemical imaging to map the distribution of cancer throught the body. With the growing list of radiopharmaceutical and quantitative techniques applicable to cancer studies with PET, this field will continue to realize significant growth. © 1991 W.B. Saunders Company. All rights reserved.
引用
收藏
页码:268 / 284
页数:17
相关论文
共 140 条
[41]   BACTERIAL OSTEOMYELITIS - FINDINGS ON PLAIN RADIOGRAPHY, CT, MR, AND SCINTIGRAPHY [J].
GOLD, RH ;
HAWKINS, RA ;
KATZ, RD .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1991, 157 (02) :365-370
[42]   CHARACTERIZATION OF A WHOLE-BODY IMAGING TECHNIQUE FOR PET [J].
GUERRERO, TM ;
HOFFMAN, EJ ;
DAHLBOM, M ;
CUTLER, PD ;
HAWKINS, RA ;
PHELPS, ME .
IEEE TRANSACTIONS ON NUCLEAR SCIENCE, 1990, 37 (02) :676-680
[43]  
HABERKORN U, 1991, J NUCL MED, V32, P1548
[44]  
HABERKORN U, 1991, J NUCL MED, V32, P1485
[45]   UPTAKE OF 2-DEOXY, 2-(18F) FLUORO-D-GLUCOSE IN BLADDER-CANCER - ANIMAL LOCALIZATION AND INITIAL PATIENT POSITRON EMISSION TOMOGRAPHY [J].
HARNEY, JV ;
WAHL, RL ;
LIEBERT, M ;
KUHL, DE ;
HUTCHINS, GD ;
WEDEMEYER, G ;
GROSSMAN, HB .
JOURNAL OF UROLOGY, 1991, 145 (02) :279-283
[46]  
HAWKINS RA, 1992, J NUCL MED, V33, P633
[47]   PET IN CLINICAL ONCOLOGY [J].
HAWKINS, RA ;
PHELPS, ME .
CANCER AND METASTASIS REVIEWS, 1988, 7 (02) :119-142
[48]   EFFECTS OF TEMPORAL SAMPLING, GLUCOSE METABOLIC RATES, AND DISRUPTIONS OF THE BLOOD-BRAIN-BARRIER ON THE FDG MODEL WITH AND WITHOUT A VASCULAR COMPARTMENT - STUDIES IN HUMAN-BRAIN TUMORS WITH PET [J].
HAWKINS, RA ;
PHELPS, ME ;
HUANG, SC .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1986, 6 (02) :170-183
[49]   ESTIMATION OF LOCAL CEREBRAL PROTEIN-SYNTHESIS RATES WITH L-[1-C-11]LEUCINE AND PET - METHODS, MODEL, AND RESULTS IN ANIMALS AND HUMANS [J].
HAWKINS, RA ;
HUANG, SC ;
BARRIO, JR ;
KEEN, RE ;
FENG, DG ;
MAZZIOTTA, JC ;
PHELPS, ME .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1989, 9 (04) :446-460
[50]  
HAWKINS RA, 1991, J NUCL MED, V32, P1555